Evidence map›Paper›PMID 31699025›Full record

ArticleBMC genomics2019

Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance.

Xiaoling Yu, Wen Zhang, Zhiping Zhao, Chengsong Ye, Shuyan Zhou, Shaogui Wu, Lifen Han, Zhaofang Han, Hanhui Ye

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Infection and drug resistance · 2025
    Review
  8. Article
  9. Article
  10. Clinical and genomic characterization of carbapenem-resistantFrontiers in cellular and infection microbiology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Draft genome sequence ofAccess microbiology · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Xiaoling YuDepartment of Infectious Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, Fujian, People's Republic of China.
Wen ZhangFriedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Zhiping ZhaoDepartment of Infectious Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, Fujian, People's Republic of China.
Chengsong YeKey Lab of Urban Environment and Health, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen, 361021, Fujian, People's Republic of China.
Shuyan ZhouDepartment of Microbiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, Fujian, People's Republic of China.
Shaogui WuDepartment of Microbiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, Fujian, People's Republic of China.
Lifen HanDepartment of Infectious Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, Fujian, People's Republic of China.
Zhaofang HanState Key Laboratory of Marine Environmental Science, College of Ocean and Earth Sciences, Xiamen University, Xiamen, 361102, Fujian, People's Republic of China. zhaofang_han@foxmail.com.
Hanhui YeDepartment of Infectious Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, Fujian, People's Republic of China. 15960102808@163.com.
Fujian Medical University · CNMengchao Hepatobiliary Hospital · CNIcahn School of Medicine at Mount Sinai · USInstitute of Urban Environment · CNXiamen University · CN

Funding

Clinical Medicine Center Construction Program of Fuzhou, Fujian, P.R.C. 2018080306Health Research Innovation Team Cultivation Project of Fuzhou, P.R.C. 2019-S-wt4Key Clinical Specialty Discipline Construction Program of Fujian, P.R.China. N/AKey Clinical Specialty Discipline Construction Program of Fuzhou, P.R.China 201510301
6 · The paper itself

Abstract

backgroundThe enhancing incidence of carbapenem-resistant Klebsiella pneumoniae (CRKP)-mediated infections in Mengchao Hepatobiliary Hospital of Fujian Medical University in 2017 is the motivation behind this investigation to study gene phenotypes and resistance-associated genes of emergence regarding the CRKP strains. In current study, seven inpatients are enrolled in the hospital with complete treatments. The carbapenem-resistant K. pneumoniae whole genome is sequenced using MiSeq short-read and Oxford Nanopore long-read sequencing technology. Prophages are identified to assess genetic diversity within CRKP genomes.

resultsThe investigation encompassed eight CRKP strains that collected from the patients enrolled as well as the environment, which illustrate that bla

conclusionsST11 is the main CRKP type, and bla

Indexed as

Anti-Bacterial AgentsCarbapenemsDrug Resistance, BacterialGenome-Wide Association StudyGenomicsHumansKlebsiella pneumoniaeMolecular Sequence AnnotationPhylogenyPolymorphism, Single NucleotideAnti-Bacterial AgentsCarbapenemsbla KPC-2Carbapenem-resistantKlebsiella pneumoniaeWhole-genome sequencing

Identifiers

PMID31699025
PMCPMC6839148
OpenAlexW2987898767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.